BioNTech taps Sobi executive Oelkers as its next CEO
Guido Oelkers will guide BioNTech’s ongoing transition into an oncology-focused biotech, while co-founder and longtime leader Ugur Sahin prepares to join a fledgling mRNA startup.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.